SEI Investments’s SpringWorks Therapeutics SWTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-5,588
Closed -$263K 2905
2025
Q2
$263K Sell
5,588
-36,916
-87% -$1.64M ﹤0.01% 2459
2025
Q1
$1.88M Buy
42,504
+14,195
+50% +$653K ﹤0.01% 1661
2024
Q4
$1.02M Sell
28,309
-2,859
-9% -$99.9K ﹤0.01% 1930
2024
Q3
$999K Sell
31,168
-15,040
-33% -$562K ﹤0.01% 1947
2024
Q2
$1.74M Sell
46,208
-2,454
-5% -$103K ﹤0.01% 1696
2024
Q1
$2.4M Buy
48,662
+21,558
+80% +$997K ﹤0.01% 1549
2023
Q4
$989K Buy
27,104
+3,178
+13% +$82.9K ﹤0.01% 1882
2023
Q3
$553K Buy
23,926
+9,728
+69% +$266K ﹤0.01% 2077
2023
Q2
$372K Buy
14,198
+549
+4% +$14.4K ﹤0.01% 2245
2023
Q1
$351K Buy
13,649
+66
+0.5% +$1.93K ﹤0.01% 2276
2022
Q4
$353K Buy
+13,583
New +$335K ﹤0.01% 2146

Other funds holding SWTX

SEI Investments's SWTX Position: Q3 2025 in Review

SEI Investments sold out of SpringWorks Therapeutics (SWTX) in Q3 2025, closing a stake of 5,588 shares — an estimated $263K sold.

SEI Investments first reported a position in SWTX in Q4 2022 and held it in 11 quarters. The position peaked at $2.4M in Q1 2024. 3 funds tracked by Wall St. Rank hold SWTX as of Q3 2025.

  • SEI Investments reported no remaining SpringWorks Therapeutics position as of Q3 2025 after selling out during the quarter.
  • SEI Investments sold 5,588 SpringWorks Therapeutics shares in Q3 2025, an estimated $263K.
  • SEI Investments first reported a position in SpringWorks Therapeutics in Q4 2022 and held it in 11 quarters.
  • SEI Investments's SpringWorks Therapeutics position peaked at $2.4M in Q1 2024.
  • 3 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q3 2025.

Based on SEI Investments's 13F filing for Q3 2025, filed 13 Nov 2025.